Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGN-2009 Alone or With M7824 in HPV Positive Cancers
NCT04432597Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2020
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
A Phase 2 trial of PRGN-2009 in HPV-associated cancer, oropharyngeal cancer, Cervical Cancer (CC), anal cancer, vulvar cancer, sponsored by National Cancer Institute. Started Aug 2020; status: completed.
02
Drugs
PRGN-2009
03
Conditions
HPV-associated canceroropharyngeal cancerCervical Cancer (CC)anal cancervulvar cancer
Beyond the preview
Go deeper on NCT04432597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04432597.